>The [Best Biotech CEO of All Time] award should probably go to Celgene's CEO Sol Barer. No, he and his stock haven't done that much THIS year, but the last decade…<
The 10-year cumulative return has indeed been superlative (+4,044%), but Barer has been CEO for only the past 2.5 years, during which time the stock is up less than 20%.
I realize this is nitpicking insofar as Barer was COO for many, many years before being named CEO, but rules are rules :- )
Market Data 
Markets 
AI
